Apabetalone, a First-in-Class Epigenetic Therapeutic Candidate, Met Key Endpoint of Lowering Pulmonary Vascular Resistance (PVR) and Was Well Tolerated Successful Completion and Promising Results of Investigator-led APPROACH-p Trial Sets the Stage for a Larger Multicenter Trial CALGARY, Alberta, Sept. 08, 2021 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) […]
Author: Ken Dropiewski
Investor Insights: Maria Berkman, MD, Director, Head of MedTech for Broadview Ventures
Investor Insights highlights some of the top investors in Life Science and MedTech. This week host Ken Dropiewski interviews Maria Berkman, MD, Director, Head of MedTech for Broadview Ventures.
TransMedics Receives FDA Approval for its OCS Heart System Enabling Broader Utilization of Donor Hearts for Transplantation in the U.S.
ANDOVER, Mass., Sept. 7, 2021 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of its OCS Heart System for […]
Cardio Partners, a Sarnova company, Announce the Acquisition of Allied 100
The combination of companies expands access to sudden cardiac arrest (SCA) preparedness solutions to customers nationwide BRENTWOOD, Tenn., Sept. 7, 2021 /PRNewswire/ — Cardio Partners, Inc., a company of Sarnova, Inc. and a national leader in providing emergency preparedness solutions, announced today that it has acquired Allied 100, LLC, a nationwide distributor of automated external […]
Peijia Medical Engages Professor Saibal Kar as Exclusive Consultant
To Advise the Company’s Mitral Transcatheter Edge-to-edge Repair Project and the Company in General SUZHOU, China, Sept. 6, 2021 /PRNewswire/ — Peijia Medical Limited (HKEX: 9996) is pleased to announce Saibal Kar MD, FACC, FSCAI, board-certified interventional cardiologist has agreed to become our exclusive consultant in China to advise the research and development of our Mitral Transcatheter […]
XACT Robotics® Appoints New Vice President, Sales and Marketing
Christopher Horton brings nearly 30 years of experience in the medical device and technology industry HINGHAM, Mass., Sept. 7, 2021 /PRNewswire/ — XACT Robotics®, the developer of the world’s first and only hands-free robotic system for CT-guided percutaneous procedures, the XACT ACE™ Robotic System, today announced that Christopher Horton has joined the company as […]
New health economic study proves the value of CADScor® in coronary disease diagnostics
A peer-reviewed publication in the September 2021 edition of PharmacoEconomics shows an estimated 12.3£ million savings to the English health care system per 100,000 eligible patients when using the Acarix CADScor system to rule out coronary artery disease (CAD). Coronary artery disease (CAD) is the most common heart and circulatory […]
Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLC
Acquisition builds upon Abbott’s leading vascular portfolio, adding mechanical thrombectomy devices for treating patients with peripheral blood clots ABBOTT PARK, Ill., Sept. 2, 2021 /PRNewswire/ — Abbott (NYSE: ABT) announced today that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood […]
CVR Medical Corp. Announces New Chief Executive Officer
Vancouver, British Columbia–(Newsfile Corp. – September 2, 2021) – CVR Medical Corp. (TSXV: CVM) (OTC Pink: CRRVF) (“CVR Medical” or the “Company” or “we“) a Canadian listed and US based healthcare company in the medical device market is pleased to announce the appointment of Darren Day as Chief Executive Officer (CEO), effective […]
Chardan Healthcare Acquisition 2 Corp. Announces Stockholder Approval Of Business Combination With Renovacor, Inc.
NEW YORK, Sept. 1, 2021 /PRNewswire/ — Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) (“CHAQ”), a special purpose acquisition company sponsored by Chardan Capital Markets (“Chardan”), today announced the results for the proposals considered and voted upon by its stockholders at its special meeting held on September 1, 2021 (the “Special Meeting”), regarding the proposed […]



